HIV-1 regulation via protective human leukocyte antigen (HLA) haplotypes

December 13, 2017, Kumamoto University
The HLA-B*52:01 and -C*12:02-restricted CTLs strongly suppress HIV-1 replication resulting in slower disease progression. In contrast, the HLA-B*52:01-C*12:02 haplotypes are susceptible to autoimmune diseases. Credit: Professor Masafumi Takiguchi

Twenty percent of the Japanese population have a group of genes inherited from a single parent (haplotype) that, while connected to ulcerative colitis and Takayasu arteritis, is known to be protective against HIV-1.

Researchers from the Center for AIDS Research at Kumamoto University previously found that HLA-B*52:01 and -C*12:02 haplotypes associate with lower plasma viral loads (pVL) and higher CD4 counts than patients with neither haplotype and that HLA-B*52:01 can suppress HIV-1 replication by producing HIV-1-specific cytotoxic T lymphocytes (CTLs). However, direct evidence of HLA-C alleles and their related CTLs controlling HIV-1 have remained obscured until now.

In a previous study of natural killer (NK) cells, the Kumamoto researchers found that HIV-1 infected patients with a combination of HLA-C*12:02 and KIR2LD2 (a receptor for HLA-C*12:02) had a lower pVL than patients with just one or neither of those immunological constituents. They indicated that, like HLA-B, the HLA-C group also plays a part in regulating HIV-1. However, due to the strong linkage between the two alleles, distinguishing which of the two effects the HIV-1 virus has been difficult to determine.

To overcome this problem, the researchers searched for particular parts (T cell epitopes) of antigens to determine which produced the strongest to the HLA-C*12:02 haplotype. In a population of HIV-1 infected Japanese HLA-C*12:02 carriers, they were able to identify Nef MY9 and Pol IY11 as immunodominant epitopes, thereby showing that HLA-C supplements HLA-B's control of HIV-1 in infected individuals.

"Unfortunately, this haplotype is associated with several other diseases in the Japanese population," said Professor Masafumi Takiguchi, leader of the research project. "Though they can evidently control HIV-1, they may also cause other autoimmune diseases or even allergies when the immune response is too strong. Even so, this study adds a piece to the AIDS research knowledge puzzle."

Explore further: Single HIV mutation induces distinct T cell immune responses

More information: Takayuki Chikata et al, Control of HIV-1 by an HLA-B*52:01-C*12:02 Protective Haplotype, The Journal of Infectious Diseases (2017). DOI: 10.1093/infdis/jix483

Related Stories

Single HIV mutation induces distinct T cell immune responses

September 6, 2016
In an effort to increase the understanding of HIV and cytotoxic T lymphocyte (CTL) co-evolution, and improve the development of T cell-mediated AIDS vaccines, which induce the creation of HIV-specific T cells within the body, ...

A new method for removing cells infected with the AIDS virus

October 2, 2017
With the successful suppression of the AIDS virus (HIV) through medication, the focus turns toward its eradication. Researchers from Kumamoto University in Japan have developed a new compound that is key to the destruction ...

Researchers genetically engineer immune cells into potent weapons for battling HIV

March 7, 2008
By outfitting immune-system killer cells with a new pair of genes, scientists at the Albert Einstein College of Medicine of Yeshiva University transformed them into potent weapons that destroy cells infected with HIV, the ...

Four big insights into HIV/AIDS that provide hope of finding a vaccine

November 24, 2017
HIV remains one of the continent's most intractable health challenges. Tremendous progress is being made to understand the virus, the immune mechanisms that contribute to its control and for new antiretroviral drugs and vaccines ...

New autoimmune disease triggered by thymomas

March 2, 2017
A Japanese research group has discovered that a newly-identified autoimmune endocrine disease that leads to hypopituitarism is caused by thymomas (a type of tumor originating from the thymic gland). These underlying mechanisms ...

Viral recombination another way HIV fools the immune system

July 21, 2008
When individuals infected with HIV become infected with a second strain of the virus, the two viral strains can exchange genetic information, creating a third, recombinant strain of the virus. It is known that the presence ...

Recommended for you

Study shows how HIV is shielded from immune attack

July 10, 2018
Scientists from UNSW Sydney and the UK have discovered that the human immunodeficiency virus (HIV) hijacks a small molecule from the host cell to protect itself from being destroyed by the host's immune system.

Out-of-pocket costs put HIV prevention drug out of reach for many at risk

July 4, 2018
Public health officials are expanding efforts to get the HIV prevention pill into the hands of those at risk, in a nationwide effort to curb infections. But the officials are hitting roadblocks—the drug's price tag, which ...

New simulation tool predicts how well HIV-prophylaxis will work

June 14, 2018
A new mathematical simulation approach predicts the efficacy of pre- and post-exposure prophylaxis (PrEP) medications, which help prevent HIV infection. The framework, presented in PLOS Computational Biology by Sulav Duwal ...

Many at risk for HIV despite lifesaving pill

June 11, 2018
Multiple barriers may stop high-risk individuals from accessing an HIV drug that can reduce the subsequent risk of infection, according to a new University of Michigan study.

Active HIV in large white blood cells may drive cognitive impairment in infected mice

June 7, 2018
Macrophages, large white blood cells that engulf and destroy potential pathogens, harbor active viral reserves that appear to play a key role in impaired learning and memory in mice infected with a rodent version of HIV. ...

HIV vaccine elicits antibodies in animals that neutralize dozens of HIV strains

June 4, 2018
An experimental vaccine regimen based on the structure of a vulnerable site on HIV elicited antibodies in mice, guinea pigs and monkeys that neutralize dozens of HIV strains from around the world. The findings were reported ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.